by mg6754@ | Aug 15, 2022 | Pharmacogenomics
Pharmacogenomic Testing: What is it and who should get it? Recent decades have seen a rise in precision (or personalised) medicine due to rapid advances in genetics and a better understanding of the human brain and body. There is no guarantee that two people will...
by mg6754@ | Jul 20, 2022 | Hereditary Cancer
Myogenes partners with Pink Ribbon Foundation We’re incredibly proud to announce that we have officially partnered up with Pink Ribbon Foundation to help raise awareness of breast cancer and its early detection and treatment.? We believe there’s no place for...
by mg6754@ | Apr 5, 2022 | Genetic Testing
We have the technology to start a new era in medicine by precisely matching drugs to people’s genetic code, a major report says.Some drugs are completely ineffective or become deadly because of subtle differences in how our bodies function.The British Pharmacological...
by mg6754@ | Apr 5, 2022 | Genetic Testing
Pharmacogenomic testing could save the NHS money in the long term and reduce the risks of side-effects. Genetic testing to predict how individuals will respond to common medicines should be implemented without delay to reduce the risk of side-effects and ensure that...
by mg6754@ | Nov 22, 2021 | Pharmacogenomics
Getting Pharmacogenomicsinto the Clinic This Medical News Article Discusses Barriers to Widespread Implementation of Genotype-Guided Prescribing What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to...
Recent Comments